Obstructive Lung Disease Market Outlook Analysis 2034: In-Depth Research on Industry Size, Current and Emerging Growth Factors by 2034

0
928

Obstructive Lung Disease Market Highlights

The obstructive lung disease market Size was valued at USD 23.84 Billion in 2023. The Global Obstructive Lung Disease industry is projected to grow from USD 24.32 Billion in 2024 to USD 52.16 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.12% during the forecast period (2024 - 2032).

The use of drugs has emerged as an effective solution for the treatment of COPD and asthma, which largely contributes to the growth of the global obstructive lung disease market. The market is driven by the growing COPD and asthmatic patient population, as well as the FDA approval for novel products and its wide acceptance. Increasing government initiatives to control COPD and asthma further, fuel the growth of this market.

Due to the rising instances of COPD across the globe, it has become indispensable for organizations to offer promising healthcare solutions to reduce health complications. With a considerable part of population being infected by the disease, renowned COPD drug manufacturers are facing the need to reduce inflammation and improve patient health outcomes.

Regional Analysis

Global obstructive lung disease consists of regions namely the Americas, Europe, Asia Pacific, and the Middle East and Africa.

North America together dominates the gloabal asthma and COPD market followed by the European market. Rising prevalence of asthma and COPD due to pollution, changing lifestyle, and the entry of generic and novel therapies in the market.

Asia Pacific is anticipated to be the fastest growing market over the forecast period. Emerging economies such India, China due to industrialization, demographic changes, and urbanization are witnessing increased levels of pollution, thus favoring the rising prevalence of asthma and COPD population.

Segmentation

The obstructive lung disease is segmented on the basis of disease type, product type, drug class, route of administration and end-users.

On the basis of disease type, the market is segmented into asthma, bronchiectasis, bronchitis and chronic obstructive pulmonary disease (COPD), and others 

On the basis of product type, market is segmented into inhalers, and nebulizers. Inhalers are divided into Drug Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), Soft Mist Inhalers (SMIs). Moreover, nebulizers are divided into compressor nebulizers, ultrasonic nebulizers, and mesh nebulizers

On the basis of drug class, the market is segmented into combination drugs, leukotriene antagonists (LTA), inhaled corticosteroids (ICS), anticholinergics, short acting beta agonists (SABA), long-acting beta agonists (LABA), and others. Furthermore, the combination products are divided into seretide/advair, symbicort, relvar/breo ellipta, flutiform, dulera, and others. Leukotriene Antagonists (LTA) is divided into singulair and others. Inhaled Corticosteroids (ICS) is divided into qvar, pulmicort, aerospan, flovent, and others. Anticholinergics is divided into Spiriva and Others. Short Acting Beta Agonists (SABA) is divided into proair, ventolin, and others.

On the basis of route of administration, market is segmented into oral, inhaler, intravenous, subcutaneous, and others

On the basis of end-user, the market is segmented into hospitals & diagnostic centers, academic institutes, pharmaceutical & biotechnology companies and others.

Key Players

Some of the key obstructive lung disease market players are GlaxoSmithKline (GSK) (U.K), Novartis AG (Switzerland), Merck & Co. (U.S), Abbott Laboratories (U.S), Boehringer Ingelheim (Germany), AstraZeneca (U.K), Roche Holding AG (Switzerland), Teva Pharmaceutical Industries (Israel), Vectura Group (U.K), Pfizer Inc. (U.S), Mylan (U.S.), Aerovance Inc. (U.S.), Alkermes Inc. (U.S.), Almirall SA. (U.S.), Genentech Inc. (U.S.), Sepracor, Inc. (U.S.), Skyepharma plc (U.S.).

Medical Penlight Market

Mitochondrial Disease Therapies Market

Myocardial Infarction Drugs Market

Peptide and Oligonucleotide CDMO Market

Pressotherapy System Market

Hotel Channel Management Software Market

Hypnotherapy Market

Rechercher
Catégories
Lire la suite
Autre
Why Businesses Should Invest in High-End Swimwear Manufacturing
In the fashion industry, swimwear holds a substantial place, with a market value expected to hit...
Par welonswimwear 2024-01-31 02:58:54 0 3KB
Autre
Divorce Attorneys - How exactly to Pick the Proper One For You
Divorce is a stressful time for everyone. There are lots of organic emotions to manage, possibly...
Par ChaunceyHeller 2023-10-30 04:06:41 0 3KB
Domicile
Electric Scooter and Motorcycle Market: Valued at $5.96 Billion in 2023
Maximize Market Research Releases Comprehensive Analysis on the Electric Scooter and Motorcycle...
Par FMCGTrends 2025-01-06 11:43:09 0 2KB
Autre
Madurai To Bangalore Cab
Book Madurai to Bangalore cab online at best price. CabBazar provides car rental services for all...
Par cabbazar34 2025-03-05 06:55:29 0 697
Health
Enzyme Inhibitor Market Trends & Forecast 2025
The Global Enzyme Inhibitor Market reached US$182.77 billion in 2023 and is expected to reach...
Par Anil 2025-02-07 19:59:45 0 866